JS
John Simard

John Simard insider trades: XBiotech (XBIT) stock buys and sales

XBiotech Last trade Oct 26, 2026 25 Form 4 filings
$0
Sold, last 12 months
0 sales
$711K
Bought, last 12 months
1 buy
8
Open-market trades
since 2021
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where John reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Oct 26, 2026XBIT↑ Buy$711K
Oct 18, 2021XBIT↓ Sell$658K
Oct 14, 2021XBIT↓ Sell$1.1M
Oct 6, 2021XBIT↓ Sell$624K
Oct 1, 2021XBIT↓ Sell$812K
Sep 27, 2021XBIT↓ Sell$753K
Sep 22, 2021XBIT↓ Sell$758K
Jul 14, 2021XBIT↓ Sell$907K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About John Simard's insider trades

John Simard is an insider at XBiotech (XBIT). Since Jul 14, 2021, John has reported 1 open-market purchase worth $711K and 7 sales worth $5.6M on SEC Form 4. In the last 12 months: 1 buy ($711K).

Their filings also include option exercises (7 filings), grants and awards (4 filings), other transactions (4 filings), inherited shares (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every XBIT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.